| John Joseph Oprendek Jr, MD | |
|
6 E Chestnut St, Augusta, ME 04330-5717 | |
| (207) 626-1409 | |
| (207) 626-1046 |
| Full Name | John Joseph Oprendek Jr |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 6 E Chestnut St, Augusta, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518034727 | NPI | - | NPPES |
| 025970 | Other | ME | ANTHEM |
| 2233095 | Other | ME | AETNA |
| 238500099 | Medicaid | ME | |
| M55184 | Other | ME | CIGNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 010264 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Joseph Oprendek Jr, MD 149 North St, Waterville, ME 04901-4974 Ph: (207) 872-1156 | John Joseph Oprendek Jr, MD 6 E Chestnut St, Augusta, ME 04330-5717 Ph: (207) 626-1409 |
News Archive
Despite pledges to leave employer-based health plans intact, benefits consultants say some firms are considering ending or reducing coverage for their workers, The Associated Press reports, adding: "That's just not going to happen, White House officials say." But an executive for the consulting firm Deloitte said, "What we are hearing in our meetings is, 'We don't want to be the first one to drop benefits, but we would be the fast second.' We are hearing that a lot."
Adult glioblastoma continues to be a difficult disease to treat, so healthcare professionals must have the most up-to-date information regarding optimal methods for diagnostic imaging and treatment of these tumors. Awareness of novel agents in clinical trials is also critical to providing the best care.
Under an obscure, 50-year-old rule, Medicaid covers residential addiction treatment only if a center has 16 or fewer beds, severely limiting options for newly covered drug addicts and alcoholics, reports The New York Times.
Acorda Therapeutics, Inc. today announced that a new analysis of AMPYRA (dalfampridine) Extended Release Tablets, 10 mg data examining walking improvement in treatment responders has been presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
› Verified 6 days ago
Dr. Carol Anne Saunders, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 6 E Chestnut St, Dept Of Pathology, Augusta, ME 04330 Phone: 207-626-1409 Fax: 207-626-1046 | |
Dr. Ross A Metzman, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 6 E Chestnut St, Mgmc Pathology, Augusta, ME 04330 Phone: 207-626-1409 | |
Liam Eirik Funte, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 30 Hospital Street, Ocme, Augusta, ME 04330 Phone: 207-624-7185 | |
Cheri Lynn Aubertine, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1410 | |
Vincent Gemellaro, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Va Ctr, Laboratory 113, Augusta, ME 04330 Phone: 207-623-8411 Fax: 207-621-7314 | |
Laura Lee Nelsen, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 6 E Chestnut St, Augusta, ME 04330 Phone: 605-670-9580 |